{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T01:16:10Z","timestamp":1788398170700,"version":"build-2803163510"},"reference-count":25,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nuclear Medicine and Biology"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1016\/j.nucmedbio.2012.10.013","type":"journal-article","created":{"date-parts":[[2013,1,24]],"date-time":"2013-01-24T08:15:54Z","timestamp":1359015354000},"page":"252-261","source":"Crossref","is-referenced-by-count":15,"title":["Analysis of [11C]methyl-candesartan kinetics in the rat kidney for the assessment of angiotensin II type 1 receptor density in vivo with PET"],"prefix":"10.1016","volume":"40","author":[{"given":"Mireille","family":"Lortie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean N.","family":"DaSilva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheryn A.","family":"Kirkpatrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tayebeh","family":"Hadizad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basma A.","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob S.B.","family":"Beanlands","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"deKemp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nucmedbio.2012.10.013_bb0005","first-page":"11","article-title":"Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases","volume":"52","author":"Kim","year":"2000","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.nucmedbio.2012.10.013_bb0010","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1161\/01.HYP.21.2.173","article-title":"Regional angiotensin II production in essential hypertension and renal artery stenosis","volume":"21","author":"Admiraal","year":"1993","journal-title":"Hypertension"},{"key":"10.1016\/j.nucmedbio.2012.10.013_bb0015","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1161\/01.CIR.100.20.2093","article-title":"Angiotensin II type 1A receptor knockout mice display less left ventricular remodeling and improved survival after myocardial infarction","volume":"100","author":"Harada","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.nucmedbio.2012.10.013_bb0020","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1161\/hh0701.089175","article-title":"Enhanced angiotensin II activity in heart failure: reevaluation of the counterregulatory hypothesis of receptor subtypes","volume":"88","author":"Opie","year":"2001","journal-title":"Circ Res"},{"key":"10.1016\/j.nucmedbio.2012.10.013_bb0025","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0272-6386(97)90023-8","article-title":"The role of angiotensin II in diabetic nephropathy: emphasis on nonhemodynamic mechanisms","volume":"29","author":"Wolf","year":"1997","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nucmedbio.2012.10.013_bb0030","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1136\/heart.83.1.76","article-title":"Postinfarction left ventricular remodelling: where are the theories and trials leading us?","volume":"83","author":"Yousef","year":"2000","journal-title":"Heart"},{"key":"10.1016\/j.nucmedbio.2012.10.013_bb0035","first-page":"307","article-title":"In vivo labeling of angiotensin II receptors with a carbon-11-labeled selective nonpeptide antagonist","volume":"37","author":"Kim","year":"1996","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2012.10.013_bb0040","first-page":"94","article-title":"In vivo investigation of estrogen regulation of adrenal and renal angiotensin (AT1) receptor expression by PET","volume":"45","author":"Owonikoko","year":"2004","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2012.10.013_bb0045","first-page":"1209","article-title":"Investigation of angiotensin II\/AT1 receptors with carbon-11-L-159,884: a selective AT1 antagonist","volume":"39","author":"Szabo","year":"1998","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2012.10.013_bb0050","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1681\/ASN.V1271350","article-title":"Use of positron emission tomography to study AT1 receptor regulation in vivo","volume":"12","author":"Szabo","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nucmedbio.2012.10.013_bb0055","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1007\/s00259-007-0667-z","article-title":"Chronic ACE inhibitor treatment increases angiotensin type 1 receptor binding in vivo in the dog kidney","volume":"35","author":"Zober","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.nucmedbio.2012.10.013_bb0060","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.nucmedbio.2003.10.014","article-title":"A novel radioligand for imaging the AT1 angiotensin receptor with PET","volume":"31","author":"Mathews","year":"2004","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2012.10.013_bb0065","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1161\/HYPERTENSIONAHA.107.102715","article-title":"Positron-emission tomography imaging of the angiotensin II subtype 1 receptor in swine renal artery stenosis","volume":"51","author":"Xia","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.nucmedbio.2012.10.013_bb0070","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.nucmedbio.2005.08.005","article-title":"PET imaging of the AT1 receptor with [11C]KR31173","volume":"33","author":"Zober","year":"2006","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2012.10.013_bb0075","doi-asserted-by":"crossref","first-page":"7971","DOI":"10.1016\/j.bmc.2009.10.016","article-title":"Novel O-[11C]methylated derivatives of candesartan as angiotensin II AT1 receptor imaging ligands: radiosynthesis and ex vivo evaluation in rats","volume":"17","author":"Hadizad","year":"2009","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.nucmedbio.2012.10.013_bb0080","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1021\/jm00067a016","article-title":"Nonpeptide angiotensin II receptor antagonists. Synthesis and biological activity of benzimidazolecarboxylic acids","volume":"36","author":"Kubo","year":"1993","journal-title":"J Med Chem"},{"key":"10.1016\/j.nucmedbio.2012.10.013_bb0085","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.nucmedbio.2008.01.004","article-title":"Use of a column-switching high-performance liquid chromatography method to assess the presence of specific binding of (R)- and (S)-[11C]rolipram and their labeled metabolites to the phosphodiesterease-4 enzyme in rat plasma and tissues","volume":"35","author":"Kenk","year":"2008","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2012.10.013_bb0090","series-title":"PET pharmacokinetic course manual","first-page":"67","article-title":"Receptor kinetics \u2014 modelling and practical approach","author":"Lammertsma","year":"2008"},{"key":"10.1016\/j.nucmedbio.2012.10.013_bb0095","first-page":"R665","article-title":"Multiexponential, multicompartmental, and noncompartmental modeling. II. Data analysis and statistical considerations","volume":"246","author":"Landaw","year":"1984","journal-title":"Am J Physiol"},{"key":"10.1016\/j.nucmedbio.2012.10.013_bb0100","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/jcbfm.1990.127","article-title":"Graphical analysis of reversible radioligand binding from time\u2013activity measurements applied to [N-11C-methyl]-(\u2212)-cocaine PET studies in human subjects","volume":"10","author":"Logan","year":"1990","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.nucmedbio.2012.10.013_bb0105","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1021\/jm0204237","article-title":"Angiotensin II AT1 receptor antagonists. Clinical implications of active metabolites","volume":"46","author":"Schmidt","year":"2003","journal-title":"J Med Chem"},{"key":"10.1016\/j.nucmedbio.2012.10.013_bb0110","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0969-8051(00)00138-4","article-title":"PET physiological measurements using constant infusion","volume":"27","author":"Carson","year":"2000","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2012.10.013_bb0115","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/00004647-200106000-00002","article-title":"Positron emission tomography compartmental models","volume":"21","author":"Gunn","year":"2001","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.nucmedbio.2012.10.013_bb0120","unstructured":"Clinical pharmacology\/biopharmaceutics review NDA 20\u2013838. Astra Merck; 1997."},{"key":"10.1016\/j.nucmedbio.2012.10.013_bb0125","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jacc.2009.03.049","article-title":"Quantification of myocardial flow reserve using positron emission imaging. The journey to clinical use","volume":"54","author":"Beanlands","year":"2009","journal-title":"J Am Coll Cardiol"}],"container-title":["Nuclear Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805112002727?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805112002727?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,2,6]],"date-time":"2022-02-06T18:10:39Z","timestamp":1644171039000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969805112002727"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["S0969805112002727"],"URL":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2012.10.013","relation":{},"ISSN":["0969-8051"],"issn-type":[{"value":"0969-8051","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]}}}